Discovery of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine Derivatives as Highly Selective CK2 Inhibitors with Potent Cancer Cell Stemness Inhibition

MLA

Yuanjiang Wang, et al. “Discovery of 5-(3-Chlorophenylamino)Benzo[c][2,6]Naphthyridine Derivatives as Highly Selective CK2 Inhibitors with Potent Cancer Cell Stemness Inhibition.” Journal of Medicinal Chemistry, vol. 64, Apr. 2021, pp. 5082–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b21a0a77d8ceb9e8db94325e1dcaa86d&authtype=sso&custid=ns315887.

APA

Yuanjiang Wang, Zhaodan Lv, Shaohua Gou, Feihong Chen, & Xing Wang. (2021). Discovery of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine Derivatives as Highly Selective CK2 Inhibitors with Potent Cancer Cell Stemness Inhibition. Journal of Medicinal Chemistry, 64, 5082–5098.

Chicago

Yuanjiang Wang, Zhaodan Lv, Shaohua Gou, Feihong Chen, and Xing Wang. 2021. “Discovery of 5-(3-Chlorophenylamino)Benzo[c][2,6]Naphthyridine Derivatives as Highly Selective CK2 Inhibitors with Potent Cancer Cell Stemness Inhibition.” Journal of Medicinal Chemistry 64 (April): 5082–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b21a0a77d8ceb9e8db94325e1dcaa86d&authtype=sso&custid=ns315887.